Literature DB >> 7276066

Hodgkin's disease: establishment and characterization of four in vitro cell lies.

V Diehl, H H Kirchner, M Schaadt, C Fonatsch, H Stein, J Gerdes, C Boie.   

Abstract

Four in vitro cell lines (L 428, L 439, L 538, and L 540) were established from different materials of three patients with Hodgkin's disease: pleural effusions, peripheral blood, and bone marrow. The histological diagnosis was confirmed in all cases by several independent histologists. All four cell lines have been in culture for over 6 months up to over 3 years. The neoplastic nature of the culture cells is indicated by the demonstration of several structural and numeric chromosome abnormalities associated with a monoclonal pattern of marker chromosomes. EBV-specific antigens (EBNA, VCA) were not detected in either cell line. Ia-like antigens, receptors for human T cells, acid phosphatase, and acid esterase were showen to be present in the cultured cells. All cell lines lacked surface or cytoplasmic Ig, HTLA, receptors for C3b, C3d, IgG-Fc, mouse E or sheep E, and were devoid of lysozyme, peroxidase, and chloracetate esterase. The described features do not represent B cells, T cells, myeloid cells, monocytes, or macrophages. The morphology and the marker pattern of the culture cells, however, is identical with that of freshly obtained Hodgkin's (H)- and Sternberg-Reed (SR)-cells, except for the lack of CIg in the in vitro cells, which is explained by the culture conditions. Heterotransplantation in nude mice was achieved by intracranial inoculation and by s.c. transplantation of cultured cells embedded in a plasma clot. The described findings suggest that these cultured Hodgkin's cell lines are indeed derived from H and SR cells. The cellular origin of these cells is not clear, the loss of cellular differential markers during the process of possible dedifferentiation is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 7276066     DOI: 10.1007/BF00405072

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Lymphoid cell lines: in vitro cell markers in correlation to tumorigenicity in nude mice.

Authors:  V Diehl; P Krause; K P Hellriegel; M Busche; I Schedel; E Laskewitz
Journal:  Haematol Blood Transfus       Date:  1977

Review 2.  Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.

Authors:  H Stein; C S Papadimitriou; H Bouman; K Lennert; J Fuchs
Journal:  Recent Results Cancer Res       Date:  1978

3.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Letter: Possible T-lymphocyte origin of Reed-Sternberg cells.

Authors:  M Biniaminov; B Ramot
Journal:  Lancet       Date:  1974-03-02       Impact factor: 79.321

6.  New technique for distinguishing between human chromosomes.

Authors:  A T Sumner; H J Evans; R A Buckland
Journal:  Nat New Biol       Date:  1971-07-07

7.  Long term cultures of Hodgkin's tissue. A morphologic and radioautographic study.

Authors:  M E Kadin; A K Asbury
Journal:  Lab Invest       Date:  1973-02       Impact factor: 5.662

8.  Acid alpha-naphthyl acetate esterase in hairy cell leukemia cells and other cells of the hematopoietic system.

Authors:  G Tolksdorf; H Stein
Journal:  Blut       Date:  1979-09

9.  "Sternberg-reed" giant cells of Hodgkin's Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages.

Authors:  H S Kaplan; S Gartner
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

10.  Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes).

Authors:  G Tolksdorf; H Stein; K Lennert
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

View more
  38 in total

1.  Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma.

Authors:  Ewerton M Maggio; Anke Van Den Berg; Debora de Jong; Arjan Diepstra; Sibrand Poppema
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.

Authors:  D Kube; M Vockerodt; O Weber; K Hell; J Wolf; B Haier; F A Grässer; N Müller-Lantzsch; E Kieff; V Diehl; H Tesch
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma.

Authors:  Maria Kleppe; Thomas Tousseyn; Eva Geissinger; Zeynep Kalender Atak; Stein Aerts; Andreas Rosenwald; Iwona Wlodarska; Jan Cools
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

4.  Cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.

Authors:  S M Hsu; S S Xie; P L Hsu
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay.

Authors:  G Krupp; K Kühne; S Tamm; W Klapper; K Heidorn; A Rott; R Parwaresch
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

Review 6.  Cytogenetics of malignant lymphomas.

Authors:  C Fonatsch
Journal:  Blut       Date:  1988-09

7.  Serum antibodies to a normal cellular protein (P-65) in patients with Hodgkin's disease.

Authors:  F W Hirsch; J Scholl; G Dölken
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

8.  BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.

Authors:  S L Locatelli; L Cleris; G G Stirparo; S Tartari; E Saba; M Pierdominici; W Malorni; A Carbone; A Anichini; C Carlo-Stella
Journal:  Leukemia       Date:  2014-02-24       Impact factor: 11.528

9.  Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.

Authors:  H Kreipe; H H Wacker; H J Heidebrecht; K Haas; M Hauberg; M Tiemann; R Parwaresch
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

10.  Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.

Authors:  R K Gupta; K Patel; W F Bodmer; J G Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.